NDC51407-0524-01: CLONAZEPAM TABLETS.
The CLONAZEPAM TABLETS is a the manufacturer industrial component. Key specifications include special_features: CLASS 4, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: CLONAZEPAM TABLETS USP 0.5 MG 100S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-049-6735, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | CLASS 4 |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CLONAZEPAM TABLETS USP 0.5 MG 100S BT |
| NSN | 6505-01-049-6735 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | CLASS 4 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 0.5 MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.